trending Market Intelligence /marketintelligence/en/news-insights/trending/gGAX0KlEHXKPLpZJecLYOw2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Proxy adviser backs Sabra-Care Capital merger deal

Gauging Supply Chain Risk In Volatile Times

The Commercial Real Estate CRE Sector Feels the Impact of the Coronavirus

Credit Analytics Case Study Poundworld Retail Ltd

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Proxy adviser backs Sabra-Care Capital merger deal

Glass Lewis & Co. LLC recommended that Sabra Health Care REIT Inc. shareholders vote in favor of the company's proposed common share issuance as part of its planned merger with Care Capital Properties Inc.

The recommendation was contrary to that made by Sabra shareholders Hudson Bay Capital Management LP and Eminence Capital LP, which both objected to the deal. Glass Lewis said in an Aug. 3 report that both opposing shareholders "have misrepresented Sabra's strategic objectives and certain of its communications surrounding the CCP acquisition." The proxy adviser also questioned whether Hudson Bay's and Eminence's interests are in line with the long-term interests of Sabra and its other stockholders.

In its report, Glass Lewis said it believes the CCP transaction is appropriately valued and that Sabra's management and board are well-equipped to assess the deal, manage CCP's portfolio and serve the interests of Sabra stockholders.

Sabra lauded the proxy adviser's recommendation and said its board is calling on shareholders to approve the proposed common share issuance at the company's special meeting scheduled for Aug. 15.